X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1109) 1109
chondrosarcoma - metabolism (569) 569
animals (540) 540
chondrosarcoma (511) 511
index medicus (476) 476
male (462) 462
chondrosarcoma - pathology (428) 428
female (405) 405
adult (317) 317
middle aged (310) 310
bone neoplasms - metabolism (304) 304
bone neoplasms - pathology (300) 300
cell line, tumor (264) 264
oncology (262) 262
rats (258) 258
immunohistochemistry (255) 255
biochemistry & molecular biology (250) 250
pathology (235) 235
chondrosarcoma - genetics (218) 218
aged (208) 208
cell biology (208) 208
expression (205) 205
tumors (178) 178
mice (173) 173
cancer (161) 161
cartilage (151) 151
bone neoplasms - genetics (144) 144
adolescent (142) 142
tumor cells, cultured (132) 132
cells, cultured (128) 128
bone (127) 127
chondrocytes - metabolism (118) 118
cartilage - metabolism (114) 114
chondrocytes (105) 105
gene expression (101) 101
diagnosis, differential (100) 100
child (99) 99
molecular sequence data (99) 99
metastasis (98) 98
signal transduction (96) 96
biomarkers, tumor - metabolism (95) 95
orthopedics (92) 92
apoptosis (91) 91
chondrosarcoma - enzymology (91) 91
differentiation (91) 91
chondrosarcoma - drug therapy (88) 88
gene expression regulation, neoplastic (88) 88
sarcoma (87) 87
osteosarcoma (86) 86
cell line (85) 85
proteoglycans - metabolism (84) 84
reverse transcriptase polymerase chain reaction (84) 84
proteins (83) 83
analysis (81) 81
cells (80) 80
mutation (79) 79
prognosis (78) 78
blotting, western (77) 77
research (76) 76
rna, messenger - metabolism (76) 76
amino acid sequence (72) 72
osteosarcoma - metabolism (72) 72
proteoglycans - biosynthesis (72) 72
surgery (71) 71
kinetics (70) 70
angiogenesis (69) 69
in-vitro (68) 68
osteosarcoma - pathology (68) 68
rna, messenger - genetics (67) 67
chondrosarcoma - diagnosis (66) 66
phosphorylation (66) 66
base sequence (65) 65
chemotherapy (65) 65
gene-expression (65) 65
extraskeletal myxoid chondrosarcoma (64) 64
growth (64) 64
up-regulation (62) 62
aged, 80 and over (61) 61
bone neoplasms - drug therapy (61) 61
cattle (61) 61
research article (61) 61
cell differentiation (60) 60
cell proliferation (60) 60
swarm rat chondrosarcoma (60) 60
cartilage, articular - metabolism (59) 59
bone neoplasms - diagnosis (58) 58
gene (57) 57
osteoarthritis (57) 57
activation (56) 56
biophysics (55) 55
chondrocytes - drug effects (55) 55
signal transduction - drug effects (55) 55
protein (54) 54
human chondrosarcoma (53) 53
young adult (53) 53
extracellular matrix proteins (52) 52
genetic aspects (52) 52
collagen (51) 51
proliferation (51) 51
mice, nude (50) 50
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1382) 1382
Chinese (26) 26
Russian (19) 19
Japanese (10) 10
German (7) 7
Italian (2) 2
French (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Communications, ISSN 2041-1723, 2013, Volume 4, Issue 1, p. 2166
Isocitrate dehydrogenase (IDH) genes 1 and 2 are frequently mutated in acute myeloid leukaemia (AML), low-grade glioma, cholangiocarcinoma (CC) and... 
DNA METHYLATION | MAMMALIAN DNA | 5-METHYLCYTOSINE | MULTIDISCIPLINARY SCIENCES | TRANSCRIPTION | PHENOTYPE | RETINOIC ACID RECEPTORS | ACUTE MYELOID-LEUKEMIA | MUTATIONS | 5-CARBOXYLCYTOSINE | DISCOVERY | Neoplasms - metabolism | Humans | Leukemia, Myeloid, Acute - metabolism | Gene Expression Regulation, Neoplastic | Cholangiocarcinoma - metabolism | Bone Neoplasms - pathology | Receptors, Retinoic Acid - genetics | Bone Neoplasms - metabolism | Glioma - metabolism | DNA-Binding Proteins - metabolism | Glioma - genetics | DNA Methylation | Neoplasms - genetics | Glioma - pathology | Trans-Activators - genetics | Chondrosarcoma - genetics | Chondrosarcoma - pathology | Bone Neoplasms - genetics | Bile Duct Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Central Nervous System Neoplasms - metabolism | Bile Duct Neoplasms - metabolism | Signal Transduction | Leukemia, Myeloid, Acute - pathology | Central Nervous System Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Proto-Oncogene Proteins - genetics | Receptors, Retinoic Acid - metabolism | DNA-Binding Proteins - genetics | Central Nervous System Neoplasms - pathology | Cholangiocarcinoma - pathology | Chondrosarcoma - metabolism | Cholangiocarcinoma - genetics | Isocitrate Dehydrogenase - metabolism | Trans-Activators - metabolism | Glutarates - metabolism | Bile Duct Neoplasms - pathology | Mutation | Neoplasms - pathology | Leukemia, Myeloid, Acute - genetics
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 10/2011, Volume 35, Issue 10, pp. e47 - e63
Significant progress has been made in understanding the molecular genetic alterations involved in sarcomagenesis. Cytogenetic and molecular studies have... 
malignant rhabdoid tumor | SMARCB1 | epithelioid sarcoma | schwannomatosis | SNF5 | soft tissue tumors | renal medullarycarcinoma | INI1 | SURGERY | NERVE SHEATH TUMOR | EXTRASKELETAL MYXOID CHONDROSARCOMA | PATHOLOGY | SOFT-TISSUE TUMORS | ROUND-CELL TUMOR | renal medullary carcinoma | DIFFERENTIATED SYNOVIAL SARCOMA | ATYPICAL TERATOID/RHABDOID TUMOR | OF-THE-LITERATURE | NATIONAL-WILMS-TUMOR | Myoepithelioma - metabolism | Kidney Neoplasms - genetics | Soft Tissue Neoplasms - diagnosis | Humans | Transcription Factors - deficiency | Carcinoma, Medullary - diagnosis | Carcinoma, Medullary - metabolism | Kidney Neoplasms - metabolism | DNA-Binding Proteins - deficiency | Kidney Neoplasms - diagnosis | DNA-Binding Proteins - metabolism | SMARCB1 Protein | Biomarkers, Tumor - metabolism | Sarcoma - diagnosis | Cytogenetic Analysis | Rhabdoid Tumor - metabolism | Sarcoma - genetics | Soft Tissue Neoplasms - genetics | Epithelioid Cells - pathology | Myoepithelioma - diagnosis | Chondrosarcoma - diagnosis | Chromosomal Proteins, Non-Histone - metabolism | Carcinoma, Medullary - genetics | Nerve Sheath Neoplasms - diagnosis | Soft Tissue Neoplasms - metabolism | Nerve Sheath Neoplasms - metabolism | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Chromosomal Proteins, Non-Histone - deficiency | Chromosomal Proteins, Non-Histone - genetics | Epithelioid Cells - metabolism | Immunohistochemistry - methods | Sarcoma - metabolism | Transcription Factors - metabolism | Rhabdoid Tumor - genetics | Rhabdoid Tumor - diagnosis
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2012, Volume 181, Issue 5, pp. 1782 - 1795
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 10/2012, Volume 227, Issue 10, pp. 3488 - 3497
Journal Article
Histopathology, ISSN 0309-0167, 07/2013, Volume 63, Issue 1, pp. 36 - 49
Journal Article
Veterinary Pathology, ISSN 0300-9858, 7/2016, Volume 53, Issue 4, pp. 781 - 787
Osteosarcoma (OSA) is a malignant heterogeneous primary bone tumor responsible for up to 90% of all primary bone tumors in dogs. In this study, osteocalcin... 
bone tumors | osteonectin | osteoid | chondrosarcoma | osteocalcin | canine | immunohistochemistry | osteosarcoma | DIAGNOSIS | PROGNOSTIC-FACTORS | IMMUNOREACTIVITY | IRREGULAR BONES | ANTIGENS | PATHOLOGY | TUMORS | BIOLOGY | DOGS | DECALCIFICATION | VETERINARY SCIENCES | Bone and Bones - pathology | Hemangiosarcoma - metabolism | Hemangiosarcoma - veterinary | Dog Diseases - metabolism | Histiocytic Sarcoma - diagnosis | Antibodies | Extracellular Matrix - metabolism | Fibrosarcoma - metabolism | Osteosarcoma - diagnosis | Bone Neoplasms - pathology | Dog Diseases - pathology | Osteosarcoma - veterinary | Bone Neoplasms - metabolism | Hemangiosarcoma - diagnosis | Sarcoma - veterinary | Fibrosarcoma - pathology | Histiocytic Sarcoma - metabolism | Bone and Bones - metabolism | Sensitivity and Specificity | Biomarkers, Tumor - metabolism | Chondrosarcoma - pathology | Sarcoma - diagnosis | Histiocytic Sarcoma - pathology | Immunohistochemistry - veterinary | Dog Diseases - diagnosis | Bone Neoplasms - veterinary | Osteosarcoma - metabolism | Hemangiosarcoma - pathology | Chondrosarcoma - diagnosis | Diagnosis, Differential | Fibrosarcoma - diagnosis | Bone Neoplasms - diagnosis | Osteocalcin - metabolism | Osteonectin - metabolism | Sarcoma - pathology | Sarcoma - metabolism | Animals | Chondrosarcoma - metabolism | Chondrosarcoma - veterinary | Histiocytic Sarcoma - veterinary | Dogs | Fibrosarcoma - veterinary | Osteosarcoma - pathology
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2016, Volume 11, Issue 5, p. e0154680
The receptor-activator of nuclear kappaB ligand (RANKL) signaling pathway plays an important role in the regulation of bone growth and mediates the formation... 
GIANT-CELL TUMOR | DENOSUMAB | MULTIDISCIPLINARY SCIENCES | Osteosarcoma - drug therapy | RANK Ligand - metabolism | Humans | Male | Antineoplastic Agents - therapeutic use | Fibrous Dysplasia of Bone - drug therapy | RNA, Messenger - metabolism | Bone Neoplasms - pathology | Giant Cell Tumor of Bone - pathology | Chondrosarcoma - genetics | Chondrosarcoma - pathology | Bone Cysts, Aneurysmal - metabolism | Bone Neoplasms - genetics | Fibrous Dysplasia of Bone - genetics | Chondroma - drug therapy | Osteoclasts - pathology | Bone Cysts, Aneurysmal - pathology | Multiple Myeloma - genetics | Osteosarcoma - pathology | Bone Cysts, Aneurysmal - drug therapy | Chondroma - genetics | Gene Expression Regulation, Neoplastic | Chondroma - metabolism | Chondroma - pathology | Bone Neoplasms - metabolism | Denosumab - therapeutic use | Multiple Myeloma - drug therapy | Giant Cell Tumor of Bone - drug therapy | RNA, Messenger - antagonists & inhibitors | Female | Bone Neoplasms - drug therapy | Giant Cell Tumor of Bone - genetics | Osteosarcoma - metabolism | Fibrous Dysplasia of Bone - pathology | RNA, Messenger - genetics | Multiple Myeloma - metabolism | Organ Specificity | Chondrosarcoma - drug therapy | Fibrous Dysplasia of Bone - metabolism | Osteoclasts - metabolism | Bone Resorption - prevention & control | RANK Ligand - genetics | Multiple Myeloma - pathology | Giant Cell Tumor of Bone - metabolism | RANK Ligand - antagonists & inhibitors | Chondrosarcoma - metabolism | Osteosarcoma - genetics | Osteoclasts - drug effects | Bone Cysts, Aneurysmal - genetics | Bone resorption | Bones | Dosage and administration | Denosumab | Growth | Analysis | Immunohistochemistry | Chondrosarcoma | Multiple myeloma | Aneurysm | Bone tumors | Metastasis | Bone surgery | Metastases | Osteoprotegerin | Signal transduction | Bone growth | Biomedical materials | Osteosarcoma | Fibrous dysplasia | Bone dysplasia | Biocompatibility | Lesions | TRANCE protein | University graduates | Dysplasia | Statistical analysis | Bone lesions | Gene expression | Osteoclastogenesis | Signaling | Bone cancer | Hospitals | Biopsy | Stromal cells | Orthopedics | Monoclonal antibodies | Ligands | Osteoclasts | Bone | Prostate cancer | Tumors
Journal Article
Journal Article
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 09/2014, Volume 15, Issue 10, pp. 17380 - 17395
Journal Article